hypertrophic cardiomyopathy
Information
- Disease name
- hypertrophic cardiomyopathy
- Disease ID
- DOID:11984
- Description
- "An intrinsic cardiomyopathy that is characterized by abnormal thickening (hypertrophy) of the heart without any obvious cause." [url:http\://en.wikipedia.org/wiki/Hypertrophic_cardiomyopathy, url:http\://www.mayoclinic.org/diseases-conditions/hypertrophic-cardiomyopathy/basics/definition/con-20030747, url:http\://www.nhlbi.nih.gov/health/health-topics/topics/cm/]
Disease area statistics
Chromosome band
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT01915615 | Active, not recruiting | HCMR - Novel Markers of Prognosis in Hypertrophic Cardiomyopathy | April 2014 | December 2024 | |
| NCT06031519 | Active, not recruiting | Impact of Liwen Procedure in Obstructive Hypertrophic Cardiomyopathy on Arrhythmias | August 22, 2023 | August 31, 2024 | |
| NCT06434415 | Active, not recruiting | Prognostic Value of Coronary Angiography-Derived Index of Microcirculatory Resistance in Hypertrophic Cardiomyopathy Patients | January 1, 2017 | May 31, 2024 | |
| NCT04706429 | Active, not recruiting | Phase 2 | The Efficacy and Mechanism of Trientine in Patients With Hypertrophic Cardiomyopathy | December 1, 2020 | October 31, 2024 |
| NCT04036799 | Active, not recruiting | PRecIsion Medicine in CardiomyopathY | January 1, 2017 | December 2023 | |
| NCT03723655 | Active, not recruiting | Phase 2/Phase 3 | A Long-Term Safety Extension Study of Mavacamten in Adults Who Have Completed MAVERICK-HCM or EXPLORER-HCM | October 5, 2018 | March 15, 2030 |
| NCT00001878 | Completed | Factors Contributing to Increased Left Ventricle Size in Patients With Abnormally Enlarged Hearts | February 1999 | August 2002 | |
| NCT00001894 | Completed | Phase 2 | A Comparison of Two Treatments: Pacemaker and Percutaneous Transluminal Septal Ablation for Hypertrophic Cardiomyopathy | August 1999 | September 2002 |
| NCT00001960 | Completed | Phase 2 | Studying the Effectiveness of Pacemaker Therapy in Children Who Have Thickened Heart Muscle | November 1999 | December 2002 |
| NCT00011076 | Completed | Phase 2 | Pirfenidone to Treat Hypertrophic Cardiomyopathy | February 2001 | April 2003 |
| NCT00035386 | Completed | Phase 2 | Alcohol Septal Ablation in Obstructive Hypertrophic Cardiomyopathy: A Pilot Study | April 2002 | April 2003 |
| NCT00001225 | Completed | Family Studies of Inherited Heart Disease | April 1987 | August 2002 | |
| NCT06397092 | Completed | Anesthetic Management for TA-BSM in HOCM | April 1, 2022 | March 31, 2024 | |
| NCT00317967 | Completed | Phase 3 | Study to Determine if Atorvastatin Reduces Size and Stiffness of Muscle in the Left Ventricle of the Heart | April 2007 | November 2010 |
| NCT00319982 | Completed | Phase 2/Phase 3 | Treatment of Preclinical Hypertrophic Cardiomyopathy With Diltiazem | January 2006 | December 2013 |
| NCT06354413 | Completed | Outcomes of Concomitant Bypass Surgery in Septal Myectomy | January 2009 | December 2023 | |
| NCT00500552 | Completed | Phase 2 | Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy | December 2006 | August 2010 |
| NCT06048562 | Completed | N/A | Incidence of Hypertrophic Cardiomyopathy in Infants of Diabetic Mothers Attending in NICU at Assiut University Children Hospital During One Year | March 20, 2019 | October 20, 2022 |
| NCT00589836 | Completed | Assessment of Left Ventricular Torsion by Echocardiography Study | June 2005 | April 2008 | |
| NCT05510180 | Completed | CVD Risk Profile in Children With HCM | May 21, 2019 | February 28, 2023 | |
| NCT05459467 | Completed | N/A | Exercise Training in Hypertrophic Cardiomyopathy: (SAFE-HCM) | January 1, 2018 | March 3, 2020 |
| NCT00821353 | Completed | Phase 3 | Antiarrhythmic Therapy Versus Catheter Ablation for Atrial Fibrillation in Hypertrophic Cardiomyopathy | January 2009 | June 2012 |
| NCT00879060 | Completed | Phase 4 | Clinical and Therapeutic Implications of Fibrosis in Hypertrophic Cardiomyopathy | November 2007 | November 2012 |
| NCT01081093 | Completed | N/A | Biventricular Pacing in Hypertrophic Cardiomyopathy After Aortic Valve Replacement | April 2010 | August 2014 |
| NCT05366101 | Completed | Phase 2/Phase 3 | Lifestyle and Pharmacological Interventions in Hypertrophic Cardiomyopathy | April 1, 2019 | March 31, 2022 |
| NCT01150461 | Completed | Phase 2 | Effect of Losartan in Patients With Nonobstructive Hypertrophic Cardiomyopathy | February 2007 | July 2010 |
| NCT05135871 | Completed | Phase 1 | Study Evaluating the Pharmacokinetics of Mavacamten in Healthy Adult Chinese Subjects | October 31, 2021 | February 28, 2022 |
| NCT01334801 | Completed | Biomarkers in Aortic Stenosis - B.A.S.S. | July 2010 | January 31, 2020 | |
| NCT01447654 | Completed | Phase 2 | Inhibition of the Renin Angiotensin System With Losartan in Patients With Hypertrophic Cardiomyopathy | November 2011 | June 2014 |
| NCT04830787 | Completed | Correlation Between Myocardial Deformation and Coronary Artery Tortuosity in Patients With Hypertrophic Cardiomyopathy | December 1, 2017 | August 1, 2022 | |
| NCT01537926 | Completed | Phase 1 | Hypertrophic Regression With N-Acetylcysteine in HCM | January 2012 | December 31, 2016 |
| NCT01559714 | Completed | A Biomarker and MRI Study on Troponin Release After Exercise in Hypertrophic Cardiomyopathy | April 2012 | May 1, 2019 | |
| NCT04712136 | Completed | N/A | Healthy-related Quality of Life and Physical Activity of Children With Cardiac Malformations | February 1, 2021 | June 20, 2023 |
| NCT01721967 | Completed | Phase 4 | Ranolazine for the Treatment of Chest Pain in HCM Patients | November 2012 | May 2016 |
| NCT01873963 | Completed | Genotype-Phenotype Associations in Pediatric Cardiomyopathy (PCM GENES) | April 2013 | March 31, 2018 | |
| NCT01912534 | Completed | Phase 2 | Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM | March 2014 | July 2019 |
| NCT02234336 | Completed | Assessment of Wall Thickness in Hypertrophic Cardiomyopathy | October 2014 | July 25, 2017 | |
| NCT04650009 | Completed | Physical Activity in Children With Inherited Cardiac Diseases | May 1, 2020 | February 1, 2021 | |
| NCT02329184 | Completed | Phase 1 | Study Evaluating the Safety, Tolerability and Preliminary Pharmacokinetics and Pharmacodynamics of MYK-461 | December 2014 | April 2016 |
| NCT04439942 | Completed | 4D-flow MRI to Assess Left Ventricular Obstruction in Hypertrophic Cardiomyopathy | June 17, 2020 | June 1, 2023 | |
| NCT04402268 | Completed | Efficacy of Risk Assessment for Sudden Cardiac Death in Patients With Hypertrophic Cardiomyopathy | October 1, 2014 | February 28, 2019 | |
| NCT04133532 | Completed | Phase 4 | Effect of Metoprolol in Post Alcohol Septal Ablation Patients With Hypertrophic Cardiomyopathy | March 5, 2020 | February 23, 2023 |
| NCT04129905 | Completed | N/A | Assessment of the Relations Between Endothelial and Venous Dysfunctions and Left Ventricular Obstruction in Genetic Hypertrophic Cardiomyopathies | October 22, 2019 | December 14, 2021 |
| NCT04112511 | Completed | Study of Myocardial Deformation Parameters in Patients With Hypertrophic Cardiomyopathy | March 1, 2015 | May 5, 2022 | |
| NCT02549664 | Completed | Exercise in Genetic Cardiovascular Conditions | May 1, 2015 | November 14, 2022 | |
| NCT02559726 | Completed | N/A | Hyper-synchronicity in Hypertrophic Cardiomyopathy (HCM) : Description, Mechanism and Origin With a Multi-imaging Approach to Predict Dual Chamber Pacing Response | June 22, 2015 | January 19, 2019 |
| NCT04056715 | Completed | Extended ECG Monitoring in HCM Patients | January 14, 2020 | April 18, 2022 | |
| NCT02590809 | Completed | Phase 2 | Hypertrophic Cardiomyopathy Symptom Release by BX1514M | October 7, 2015 | July 6, 2016 |
| NCT02619825 | Completed | N/A | Non-Invasive Evaluation of Myocardial Stiffness by Elastography in Pediatric Cardiology (Elasto-Pédiatrie) | November 2015 | July 2017 |
| NCT02806479 | Completed | Hypertrophic Cardiomyopathy Pilot Study | September 2016 | September 2020 | |
| NCT03496168 | Completed | Phase 2 | Extension Study of Mavacamten (MYK-461) in Adults With Symptomatic Obstructive Hypertrophic Cardiomyopathy Previously Enrolled in PIONEER | April 26, 2018 | November 9, 2023 |
| NCT00001396 | Completed | Phase 1 | Natural History and Results of Dual Chamber (DDD) Pacemaker Therapy of Children With Obstructive Hypertrophic Cardiomyop... | October 6, 1993 | July 23, 2008 |
| NCT00001534 | Completed | Long Term Effects of Enalapril and Losartan on Genetic Heart Disease | September 1996 | April 2003 | |
| NCT00001631 | Completed | Phase 2 | Study of Blood Flow in Heart Muscle | August 1997 | January 2003 |
| NCT00001632 | Completed | Investigation Into the Use of Ultrasound Technique in the Evaluation of Heart Disease | September 1997 | August 2002 | |
| NCT00001746 | Completed | Screening for Inherited Heart Disease | April 1998 | April 2003 | |
| NCT03532802 | Completed | Phase 2 | The Effect of Metoprolol in Patients With Hypertrophic Obstructive Cardiomyopathy. | May 1, 2018 | September 1, 2020 |
| NCT03271385 | Completed | Differentiation HHD From HCM (EARLY-MYO-HHD) | July 1, 2017 | December 31, 2021 | |
| NCT03335332 | Completed | N/A | High Intensity Exercise for Increasing Fitness in Patients With Hypertrophic Cardiomyopathy | January 31, 2018 | December 20, 2022 |
| NCT03906734 | Completed | N/A | Mitral Valve Management During Septal Myectomy | January 10, 2016 | March 20, 2019 |
| NCT02994615 | Completed | Evaluating Microvascular Dysfunction in Symptomatic Patients With HypertroPhic CaRdiomyopathy | January 2017 | June 2020 | |
| NCT03043209 | Completed | Genomic Sequencing in Patients With HCM Undergoing Septal Myectomy | August 30, 2018 | December 28, 2022 | |
| NCT03832660 | Completed | Phase 2 | Sacubitril/Valsartan vs Lifestyle in Hypertrophic Cardiomyopathy | May 3, 2019 | June 30, 2022 |
| NCT03607669 | Completed | Manganese-Enhanced Magnetic Resonance Imaging of the Myocardium | June 1, 2018 | February 1, 2020 | |
| NCT03092843 | Completed | Functional Capacity and Quality of Life Following Septal Myectomy in Patients With HCM | March 20, 2017 | March 30, 2023 | |
| NCT03550573 | Completed | N/A | 3D Non-invasive Myocardial Electrical Propagation Mapping as a New Tool to Predict Sudden Death Risk in Patients With Hypertrophic Cardiomyopathy | January 28, 2019 | September 23, 2022 |
| NCT03537183 | Completed | N/A | Will Elevated Left Ventricle Filling Pressures Decrease by a Group Exercise Program in Patients With Hypertrophic CardioMyopathy? | September 1, 2018 | April 1, 2023 |
| NCT04050579 | Enrolling by invitation | N/A | OPIE in the Thin Interventricular Septum | September 15, 2020 | May 30, 2025 |
| NCT05100420 | Enrolling by invitation | Hypertrophic Cardiomyopathy Registry, Biobank and Imaging Data Repository | February 23, 2021 | August 23, 2027 | |
| NCT03527342 | Enrolling by invitation | Sahlgrenska Cardiomyopathy Project | June 1, 2018 | January 2029 | |
| NCT06461468 | Not yet recruiting | Hypertrophic Cardiomyopathy Federated Learning Implementation Platform | June 2024 | January 2026 | |
| NCT06210607 | Not yet recruiting | Phase 1 | A Trial of HS-10511 in Healthy Subjects | January 31, 2024 | December 31, 2024 |
| NCT06269640 | Not yet recruiting | N/A | NHLBI SESAME (SEptal Scoring Along Midline Endocardium) Early Feasibility Study | June 23, 2024 | October 1, 2027 |
| NCT06169358 | Recruiting | Screening Patients With Fabry Disease in Patients With Hypertrophic Cardiomyopathy or Left Ventricular Hypertrophy | October 1, 2023 | September 1, 2024 | |
| NCT03846297 | Recruiting | Optimisation of Decision Making for Defibrillator Implantation in Hypertrophic Cardiomyopathy | September 23, 2020 | March 2027 | |
| NCT02804269 | Recruiting | Molecular and Imaging Studies of Cardiovascular Health and Disease | July 2013 | July 2033 | |
| NCT04112290 | Recruiting | A Prospective Incident Study of Arrhythmias in Hypertrophic Cardiomyopathy | November 5, 2019 | December 2027 | |
| NCT02432092 | Recruiting | Pediatric Cardiomyopathy Mutation Analysis | April 2014 | December 31, 2030 | |
| NCT04157205 | Recruiting | N/A | Prospective Evaluation Of Exercise-Induced Cardiac Conduction Instability In Predicting Ventricular Fibrillation Events In Hypertrophic Cardiomyopathy | November 10, 2019 | November 1, 2024 |
| NCT04464655 | Recruiting | A 10-Minute Cardiovascular Magnetic Resonance Protocol for Cardiac Disease | December 12, 2019 | January 31, 2025 | |
| NCT04649034 | Recruiting | Intraventricular Stasis In Cardiovascular Disease | November 24, 2020 | December 31, 2024 | |
| NCT04684290 | Recruiting | N/A | Surgical Septal Myectomy vs Percutaneous Transluminal Alcohol Septal Ablation in Patients With Hypertrophic Obstructive Cardiomyopathy | June 30, 2021 | May 1, 2026 |
| NCT05081115 | Recruiting | Stress Echo 2030: the Novel ABCDE-(FGLPR) Protocol to Define the Future of Imaging | April 1, 2021 | December 31, 2030 | |
| NCT05182658 | Recruiting | Phase 3 | Empagliflozin in Hypertrophic Cardiomyopathy | June 1, 2022 | August 1, 2024 |
| NCT05257772 | Recruiting | N/A | Electromechanically Optimised Right Ventricular Pacing In Hypertrophic Cardiomyopathy (EMORI-HCM) | March 14, 2022 | October 1, 2025 |
| NCT01091480 | Recruiting | French Hypertrophic Cardiomyopathy Observatory | January 2010 | December 2028 | |
| NCT05577208 | Recruiting | N/A | Renal Denervation in Hypertrophic Cardiomyopathy | November 26, 2022 | December 31, 2024 |
| NCT05645939 | Recruiting | Association of Obesity and Cardiovascular Outcomes in Hypertrophic Cardiomyopathy | July 1, 2022 | December 31, 2024 | |
| NCT05750147 | Recruiting | The SMARTER Cardiomyopathy Study | March 1, 2023 | August 1, 2027 | |
| NCT05754489 | Recruiting | Exercise Oxygen Kinetic and Cardiac Output in Hypertrophic Cardiomyopathy | April 20, 2022 | April 2024 | |
| NCT05818605 | Recruiting | N/A | Exercise Intolerance in Non-obstructive Hypertrophic Cardiomyopathy | February 17, 2023 | March 1, 2027 |
| NCT05836259 | Recruiting | Phase 1 | Study of Safety and Tolerability of TN-201 in Adults With Symptomatic MYBPC3 Mutation-associated HCM | August 10, 2023 | December 2029 |
| NCT05884892 | Recruiting | Egyptian Hypertrophic Cardiomyopathy Program | January 1, 2014 | January 1, 2030 | |
| NCT05938283 | Recruiting | N/A | Pilot Study of Hypertrophic Cardiomyopathy & Implantable Cardioverter Defibrillator Assessment: (Subcutaneous vs Transvenous) | January 10, 2024 | January 10, 2026 |
| NCT05939700 | Recruiting | Mavacamten Pregnancy Surveillance Program | November 19, 2023 | April 2027 | |
| NCT06181617 | Recruiting | A Study to Assess Health-Related Quality of Life in Patients With Hypertrophic Cardiomyopathy in Japan | December 6, 2023 | June 30, 2025 | |
| NCT06256913 | Recruiting | Machine Learning Approach Based on Echocardiographic Data to Improve Prediction of Cardiovascular Events in Hypertrophic Cardiomyopathy | May 6, 2023 | May 6, 2024 | |
| NCT06287892 | Recruiting | Diagnosis of HCM With AI-ECG | January 1, 2024 | December 31, 2024 | |
| NCT06290570 | Recruiting | A Study of Artificial Intelligence ECG With ECG Devices to Detect Hypertrophic Cardiomyopathy Distinct From Athlete's Heart | May 7, 2024 | September 2025 | |
| NCT06347159 | Recruiting | Phase 2 | A Study of EDG-7500 in Adult Patients With Obstructive Hypertrophic Cardiomyopathy (CIRRUS-HCM) | April 11, 2024 | March 2025 |
| NCT06368518 | Recruiting | Austrian HCM Registry | March 8, 2024 | March 2034 | |
| NCT06381778 | Recruiting | Taiwan Registry of Hypertrophic Cardiomyopathy (THIC) Research Synopsis | February 6, 2023 | December 1, 2027 | |
| NCT06400524 | Recruiting | Assessment of Cardiac Function, Microvascular Function and Cardiac Perfusion in Different Disease Stages of Hypertrophic Cardiomyopathy | May 2024 | May 2026 | |
| NCT06401343 | Recruiting | Phase 4 | Use of SGLT2i in noHCM With HFpEF | August 1, 2022 | August 1, 2025 |
| NCT06409585 | Recruiting | Cardiomyopathies and Heart Muscle Diseases: Cardiac Imaging in the Evaluation of Myocardial Fibrosis Transition | May 1, 2023 | January 1, 2026 | |
| NCT03327623 | Recruiting | Sleep Apnea and Hypertrophic Cardiomyopathy (HCM) | November 13, 2017 | June 2030 | |
| NCT03362164 | Recruiting | Evaluation of HEArt invoLvement in Patients With FABRY Disease | January 2001 | March 2032 | |
| NCT04231032 | Terminated | N/A | Paced Dyssynchrony and Myocardial Perfusion IN apiCal Hcm | June 2, 2021 | February 20, 2023 |
| NCT00156429 | Terminated | Genetic Predictors of Outcome in HCM Patients | April 22, 2009 | July 30, 2020 | |
| NCT02291237 | Terminated | Phase 2/Phase 3 | Effect of Eleclazine (GS-6615) on Exercise Capacity in Subjects With Symptomatic Hypertrophic Cardiomyopathy | February 5, 2015 | February 17, 2017 |
| NCT03249272 | Terminated | Phase 4 | Microvascular Dysfunction in Nonischemic Cardiomyopathy: Insights From CMR Assessment of Coronary Flow Reserve | September 5, 2017 | March 31, 2019 |
| NCT01230918 | Terminated | Phase 2 | Study to Develop a Non-invasive Marker for Monitoring Myocardial Fibrosis | May 2011 | April 20, 2017 |
| NCT03150342 | Unknown status | Presentations of Hypertrophic Cardiomyopathy on Myocardial Perfusion Imaging | May 8, 2017 | June 30, 2018 | |
| NCT03572569 | Unknown status | Risk Stratification in Children and Adolescents With Primary Cardiomyopathy | January 2013 | December 2020 | |
| NCT03076580 | Unknown status | An Integrative-"Omics" Study of Cardiomyopathy Patients for Diagnosis and Prognosis in China | July 1, 2015 | December 31, 2021 | |
| NCT03706001 | Unknown status | N/A | Efficacy of Psychotherapy for Improving Quality of Life in Patients With Hypertrophic Cardiomyopathy and Depression | October 20, 2018 | December 31, 2019 |
| NCT03061994 | Unknown status | Metabolomic Study of All-age Cardiomyopathy | October 2016 | October 2020 | |
| NCT03726424 | Unknown status | Outcome of Different Pathogenic Mutations in Hypertrophic Cardiomyopathy | February 25, 2011 | December 31, 2019 | |
| NCT03049995 | Unknown status | Stress Echo 2020 - The International Stress Echo Study | November 2016 | December 2021 | |
| NCT03278457 | Unknown status | Risk Stratification Using PET in HCM | May 3, 2017 | June 3, 2018 | |
| NCT02948998 | Unknown status | Phase 4 | Evaluating the Effect of Spironolactone on Hypertrophic Cardiomyopathy | May 14, 2018 | July 2020 |
| NCT02922517 | Unknown status | Predictive Factors and Consequences of Myocardial Fibrosis in Hypertrophic Cardiomyopathy | June 2014 | December 2021 | |
| NCT00315783 | Unknown status | Comparison of Data Obtained by Echocardiography and Magnetic Resonance Imaging in Hypertrophic Cardiomyopathy | April 2006 | June 2006 | |
| NCT02560467 | Unknown status | N/A | Perfusion Imaging With Myocardial Contrast Echocardiography in HCM | December 1, 2015 | September 15, 2019 |
| NCT04090437 | Unknown status | N/A | HCM-AF Ablation With ACUTUS | October 1, 2019 | February 1, 2021 |
| NCT00221832 | Unknown status | Molecular Genetic Screening and Identification of Congenital Arrhythmogenic Diseases | October 2003 | December 2011 | |
| NCT02520856 | Unknown status | New Diagnostic Strategy in Hypertrophic Cardiomyopathy | July 2015 | July 2018 | |
| NCT02500420 | Unknown status | N/A | Study of Hypertrophic Cardiomyopathy Under Stress Conditions. Concordance Between Two Complementary Tests: Stress MRI and Exercice Stress Echocardiography | December 2014 | August 2017 |
| NCT04153162 | Unknown status | N/A | Non-Invasive Radiation Ablation in Patients With Hypertrophic CardioMyopathy: NIRA-HOCM | January 2, 2020 | January 2, 2023 |
| NCT00698074 | Unknown status | Phase 3 | Diastolic Ventricular Interaction and the Effects of Biventricular Pacing in Hypertrophic Cardiomyopathy | ||
| NCT04426578 | Unknown status | Phase 2 | Role of Perhexiline in Hypertrophic Cardiomyopathy | December 1, 2020 | August 1, 2022 |
| NCT02424994 | Unknown status | Morbidity and Mortality in Patients With Hypertrophic Cardiomyopathy: a CALIBER Study | April 2015 | December 2015 | |
| NCT00430833 | Unknown status | Phase 2 | CHANCE - Candesartan in Hypertrophic Cardiomyopathy | ||
| NCT01518114 | Unknown status | N/A | Exercise Training in Patients With Hypertrophic Cardiomyopathy | December 2011 | |
| NCT00504647 | Unknown status | Phase 1 | Biventricular Pacing in Hypertrophic Cardiomyopathy | June 2006 | August 2008 |
| NCT01225978 | Unknown status | Refining Information Technology Support for Genetics in Medicine | September 2009 | December 2014 | |
| NCT03259113 | Unknown status | N/A | Insertable Cardiac Monitors in Hypertrophic Cardiomyopathy | August 16, 2017 | April 16, 2019 |
| NCT03182153 | Unknown status | Extended Ambulatory Monitoring Improves Risk Stratification in Hypertrophic Cardiomyopathy | November 2016 | December 31, 2018 | |
| NCT01873976 | Unknown status | Cardiac Biomarkers in Pediatric Cardiomyopathy (PCM Biomarkers) | June 2013 | June 2022 | |
| NCT01696370 | Unknown status | Phase 2 | Trimetazidine Therapy in Hypertrophic Cardiomyopathy | April 2012 | April 2014 |
| NCT00574821 | Withdrawn | Use of Magnetic Field Mapping in the Evaluation of Patients With Hypertrophic Heart Disease (Thick Heart Muscle) | July 2007 | December 2009 | |
| NCT04905173 | Withdrawn | N/A | Comparison of Squat-to-Stand Maneuver With Amyl Nitrite, Valsalva, and Exercise Stress Echocardiography in Inducing Latent Left Ventricular Outflow Obstruction in Hypertrophic Cardiomyopathy | November 2021 | May 2022 |
| NCT02431221 | Withdrawn | Phase 3 | Efficacy, Safety, and Tolerability of Perhexiline in Subjects With Hypertrophic Cardiomyopathy and Heart Failure | ||
| NCT00703443 | Withdrawn | The Genetics of Cardiomyopathy and Heart Failure | April 2007 | April 2007 |
- Disase is a (Disease Ontology)
- DOID:0060036
- Cross Reference ID (Disease Ontology)
- ICD9CM:425.1
- Cross Reference ID (Disease Ontology)
- KEGG:05410
- Cross Reference ID (Disease Ontology)
- MESH:D002312
- Cross Reference ID (Disease Ontology)
- NCI:C34449
- Cross Reference ID (Disease Ontology)
- ORDO:217569
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:389998005
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0007194
- Exact Synonym (Disease Ontology)
- hypertrophic obstructive cardiomyopathy
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0001639